Non Occlusive Portal Vein Thrombosis

Health And Fitness Family And Parenting

The best matching results for Non Occlusive Portal Vein Thrombosis are listed below, along with top pages, social handles, current status, FAQs, and comments. If you are facing any issues, please write detail in the comments section for the solution.

Updated: May 03, 2022

Service Status Graph

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Clinicaltrials.gov

ClinicalTrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine at the National Institutes of Health, and is the largest clinical trials database, holding registrations from over 329,000 trials from 209 countries.

Most Visited Official Pages

Login
Advanced Search
Search ClinicalTrials.gov
Home - ClinicalTrials.gov

Social Handles

FAQs

1

What is non occlusive portal vein thrombosis?

Detailed Description: Portal vein thrombosis is a common complication of liver cirrhosis, especially at the decompensated or advanced stage. The reported prevalence was 10-25% by ultrasound. The effect of PVT on the natural history of liver cirrhosis is not clear, especially the non-occlusive PVT.
2

How is non occlusive DVT treated?

The mainstay of treatment of DVT is anticoagulation therapy, whereas interventions such as thrombolysis and placement of inferior vena cava filters are reserved for special situations. The use of low-molecular-weight heparin allows for outpatient management of most patients with DVT.
3

How long can you live with portal vein thrombosis?

In adults with portal vein thrombosis, the 10-year survival rate has been reported to be 38-60%, with most of the deaths occurring secondary to the underlying disease (eg, cirrhosis, malignancy).
4

How is portal vein thrombosis treated?

Most patients with PVT are treated with immediate anticoagulation therapy. [1,4] This is most often performed through continuous intravenous heparin infusion, but some authors report using low-molecular-weight heparin. Chronic treatment options include warfarin or low-molecular-weight heparin.
5

What clinical trials pay the most?

The therapeutic area can also impact payment — cardiovascular disease, neurology, endocrine, gastrointestinal, and blood disorders trials tend to pay the most.
6

How much do you get paid for clinical trials?

Clinical trials generally pay between $50-$300 per day/visit, with compensation dependant upon the length of the time required as well as the procedures performed. Overnight stays typically pay more money than those involving repeat visits.
7

Is ClinicalTrials.gov reliable?

ClinicalTrials.gov is a US government web-based resource maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH) where clinical studies can be registered, information updated, and if required, results and documents posted.
8

Is participating in clinical trials safe?

Yes, all clinical trials have risks. But any medical test, treatment, or procedure has risks. The risk may be higher in a clinical trial because there are more unknowns. This is especially true of phase I and II clinical trials, where the treatment has been studied in fewer people.
2. Nih.gov

Update on Management of Portal Vein Thrombosis and the Role

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609842/
0
DISLIKE
REPORT

Similar Portals

Report Portal Issue

If Non Occlusive Portal Vein Thrombosis is not working properly, share the problem detail below.

Your form was successfully submitted.
There was an error sending your form. Please try it again.